Wuwei Tang Combined with Gemcitabine Cisplatin in Non-small Cell Lung Cancer with Postoperative Adjuvant Chemotherapy Curative Effect Observation

WEN Shi-wang; ZHANG Yue-feng; LI Yong; LV Hui-lai; XU Yan-zhao; LI Zhen-hua; TIAN Zi-qiang

doi:10.13422/j.cnki.syfjx.2014160184

您当前的位置：

首页 >

文章列表页 >

Wuwei Tang Combined with Gemcitabine Cisplatin in Non-small Cell Lung Cancer with Postoperative Adjuvant Chemotherapy Curative Effect Observation

更新时间：2024-01-04

- Wuwei Tang Combined with Gemcitabine Cisplatin in Non-small Cell Lung Cancer with Postoperative Adjuvant Chemotherapy Curative Effect Observation
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 16, Pages: 184-186(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014160184
  CLC： R734.2
- Published：2014
- 稿件说明：
移动端阅览
WEN Shi-wang, ZHANG Yue-feng, LI Yong, et al. Wuwei Tang Combined with Gemcitabine Cisplatin in Non-small Cell Lung Cancer with Postoperative Adjuvant Chemotherapy Curative Effect Observation[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 184-186.
DOI：

WEN Shi-wang, ZHANG Yue-feng, LI Yong, et al. Wuwei Tang Combined with Gemcitabine Cisplatin in Non-small Cell Lung Cancer with Postoperative Adjuvant Chemotherapy Curative Effect Observation[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 184-186. DOI： 10.13422/j.cnki.syfjx.2014160184.

摘要

目的：探讨中药五味汤联合吉西他滨、顺铂在非小细胞肺癌术后辅助化疗的治疗效果。方法：将84例行手术治疗的非小细胞肺癌患者按照随机分组原则分成治疗组与对照组，每组42例，两组均采取吉西他滨、顺铂方案进行术后辅助化疗，28 d为1个周期，共4个周期，治疗组联合中药五味汤治疗，每日1剂，疗程4个月。化疗结束后观察两组患者近期疗效及药物毒性反应。结果：治疗组客观缓解率及中医证候总有效率均优于对照组（P<0.05），药物毒性反应明显低于对照组（P<0.05）。结论：中药五味汤联合吉西他滨、顺铂用于非小细胞肺癌术后辅助化疗，可显著增强化疗疗效，降低药物毒性反应。

Abstract

Objective: To study the Wuwei tang combined with gemcitabine and cisplatin in the treatment of non-small cell lung cancer with postoperative adjuvant chemotherapy. Method: Eighty-four patients underwent surgical treatment of non-small cell lung cancer were divided into observation group and control group in accordance with the principle of randomization group

42 cases in each group

two groups of gemcitabine and cisplatin scheme is adopted for postoperative adjuvant chemotherapy and 28 days for a cycle

a total of four cycles

observation group of combined therapy with Wuwei tang

daily 1 agent

treatment course for four months. Observe two groups of patients after chemotherapy in the near future curative effect and drug toxicity reaction. Result: The observation group of syndromes was objective response rate and total effective rate were better than control group(P<0.05)

drug toxicity reaction significantly lower than control group (P<0.05). Conclusion: Wuwei tang combined with gemcitabine and cisplatin for non-small cell lung cancer with postoperative adjuvant chemotherapy

can significantly enhance chemotherapy curative effect

reduce drug toxicity reaction.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway

Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC

Pharmacokinetic Analysis of Ziyuglycoside Ⅰ in Normal and Acute Kidney Injury Rats

Effect of Guiqi Yiyuan Ointment Combined with Cisplatin on Mice with Lewis Lung Cancer Through Endoplasmic Reticulum Stress Pathway and Mitochondrial Apoptosis Pathway

Intervention Effect and Molecular Mechanism of Dabufei Decoction in Dunhuang Formula Combined with Cisplatin on Lewis Lung Adenocarcinoma in Mice

Related Author

YU Dan

MU Qirui

LI He

LIU Yuetong

HUANG Jingyi

GAO Yuan

LI He

LIU Yuetong

Related Institution

College of Integrated Chinese and Western Medicine， Liaoning University of Traditional Chinese Medicine

College of Integrated Traditional Chinese and Western Medicine， Liaoning University of Traditional Chinese Medicine

Soochow University

Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan province & Education Ministry of P.R. China

Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰